Intellectual property law

Kaival Brands (OTCQB: KAVL): Bidi® Vapor Secures Intellectual Property Protections in China

Retrieved on: 
Thursday, July 15, 2021

GRANT, Fla., July 15, 2021 /PRNewswire/ --Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) ("Kaival Brands," the "Company," or "we"), the exclusive global distributor of products manufactured by Bidi Vapor, LLC ("Bidi Vapor"), today announced that Bidi Vapor has been granted two copyright protections and two patents by China.

Key Points: 
  • GRANT, Fla., July 15, 2021 /PRNewswire/ --Kaival Brands Innovations Group, Inc. (OTCQB: KAVL) ("Kaival Brands," the "Company," or "we"), the exclusive global distributor of products manufactured by Bidi Vapor, LLC ("Bidi Vapor"), today announced that Bidi Vapor has been granted two copyright protections and two patents by China.
  • (OTCQB: KAVL): Bidi Vapor Secures Intellectual Property Protections in China, adds to growing global IP portfolio
    The first patent, China Patent No.
  • Bidi Vapor has also secured copyrights for both the Bidi Stick and Bidi Cares names.
  • Mr. Patel went on, "These patent and copyright protections significantly bolster our global intellectual property protection portfolio we now have intellectual property protections in the United States, European Union, Australia, and China.

TrippBio receives Notice of Allowance from the U.S. Patent Office for Therapeutic Treatment of COVID-19 Infections

Retrieved on: 
Thursday, July 15, 2021

JACKSONVILLE, Fla., July 15, 2021 /PRNewswire-PRWeb/ --TrippBio, Inc. (TrippBio), a clinical development-stage company developing antiviral treatments with an initial focus on COVID-19, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No.

Key Points: 
  • JACKSONVILLE, Fla., July 15, 2021 /PRNewswire-PRWeb/ --TrippBio, Inc. (TrippBio), a clinical development-stage company developing antiviral treatments with an initial focus on COVID-19, today announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No.
  • 16/875,487, and the European Patent Office (EPO) has issued a favorable opinion in a counterpart European application.
  • The availability of safe and effective treatment options can reduce the rate of hospitalizations and hopefully the long-term effects of COVID-19."
  • TrippBio is founded on the scientific research of Ralph Tripp, Ph.D., Georgia Research Alliance Chair and professor at the University of Georgia.

Registration Opens for World's Preeminent Intellectual Property Event

Retrieved on: 
Wednesday, July 14, 2021

In opening registration for members today, the Association is encouraging early sign-ups to obtain "the best price and the best experience," said INTA CEO Etienne Sanz de Acedo.

Key Points: 
  • In opening registration for members today, the Association is encouraging early sign-ups to obtain "the best price and the best experience," said INTA CEO Etienne Sanz de Acedo.
  • In addition, early registration will help members secure a spot at sessions with limited attendance on the virtual platform and at the first-come, first-served in-person mini-conferences.
  • "INTA continues to shine as an organization that is forward-thinking and adaptable, and offers tremendous value to the intellectual property community," she said.
  • The International Trademark Association (INTA) is a global association of brand owners and professionals dedicated to supporting trademarks and related intellectual property (IP) to foster consumer trust, economic growth, and innovation.

Authentix® Completes Acquisition of Strategic IP Information Pte Ltd (SIPI) Expanding its Growth in Digital Brand Protection

Retrieved on: 
Wednesday, July 14, 2021

ADDISON, Texas, July 14, 2021 /PRNewswire/ --Authentix, the authority in authentication and information services, announced that it has acquired Asia's leading online brand and content rights protection provider, Strategic IP Information Pte Ltd (SIPI).

Key Points: 
  • ADDISON, Texas, July 14, 2021 /PRNewswire/ --Authentix, the authority in authentication and information services, announced that it has acquired Asia's leading online brand and content rights protection provider, Strategic IP Information Pte Ltd (SIPI).
  • SIPI's CEO, Bharat Kapoor added, "With the support and backing of Authentix, we are confident of becoming the world's leading service provider of online brand protection."
  • The Authentix partnership approach and proven sector expertise inspires proactive innovation, helping customers mitigate risks to promote revenue growth and gain competitive advantage.
  • Authentix is a registered trademark of Authentix, Inc.
    View original content to download multimedia: https://www.prnewswire.com/news-releases/authentix-completes-acquisition...

Clear Skye Announces Over 300% Revenue Growth in First Half 2021; Continues Global Expansion, Customer Addition, Product Innovation, and Industry Recognition

Retrieved on: 
Wednesday, July 14, 2021

Responsible enterprises realize this, and as a result, Clear Skye has more than doubled both its customer and employee roster over the first half of the year.

Key Points: 
  • Responsible enterprises realize this, and as a result, Clear Skye has more than doubled both its customer and employee roster over the first half of the year.
  • Additionally, Clear Skye was the recipient of a Cyber Defense Magazine Global InfoSec Award , and named to Startup50s Big-50-2021 list.
  • Built on ServiceNows Now Platform, Clear Skye IGA removes the need for a standalone IGA solution in favor of leveraging an existing platform.
  • Clear Skye and Clear Skye IGA are registered trademarks of Clear Skye, Inc. All other marks and names mentioned herein may be trademarks of their respective companies.

UroGen Pharma Reports Strong Preliminary Jelmyto® Sales for Second Quarter 2021

Retrieved on: 
Wednesday, July 14, 2021

Additionally, operating expenses in the second quarter of 2021 are anticipated to be in the range of $33 to $38 million.

Key Points: 
  • Additionally, operating expenses in the second quarter of 2021 are anticipated to be in the range of $33 to $38 million.
  • We look forward to reporting our full results for the second quarter of 2021 in early August.
  • The Company expects to report full financial results for the second quarter ended June 30, 2021, and host a conference call on Wednesday, August 4, 2021.
  • JELMYTO and UroGen are registered trademarks of UroGen Pharma, Ltd.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20210714005260/en/

"Open Source, Contribution, and Inspiration" -- The 2nd Anniversary of TDengine Open Source Community

Retrieved on: 
Wednesday, July 14, 2021

BEIJING, July 14, 2021 /PRNewswire/ -- On July 12, TAOS Data celebrated the second birthday of TDengine Open Source Community.

Key Points: 
  • BEIJING, July 14, 2021 /PRNewswire/ -- On July 12, TAOS Data celebrated the second birthday of TDengine Open Source Community.
  • Driven by the power of the open source community, TDengine currently serves hundreds of thousands of users across over 50 cities around the world.
  • He mentioned that it was not only the development team but also the users and contributors in the TDengine open source community that spurred TDengine to go further and stronger.
  • Stimulated by Jeff's inspiring entrepreneurship, TDengine grew to be such an innovative and energetic open source community.

Power Integrations to Release Second-Quarter Financial Results on July 29

Retrieved on: 
Wednesday, July 14, 2021

Power Integrations (Nasdaq: POWI ) will release its second-quarter financial results after market hours on Thursday, July 29, 2021, and will host a conference call that day beginning at 1:30 p.m. Pacific time.

Key Points: 
  • Power Integrations (Nasdaq: POWI ) will release its second-quarter financial results after market hours on Thursday, July 29, 2021, and will host a conference call that day beginning at 1:30 p.m. Pacific time.
  • Members of the investment community can register for the call by visiting the following link: http://www.directeventreg.com/registration/event/8646289 .
  • Power Integrations, Inc. is a leading innovator in semiconductor technologies for high-voltage power conversion.
  • Power Integrations and the Power Integrations logo are trademarks or registered trademarks of Power Integrations, Inc. All other trademarks are property of their respective owners.

LONGi has achieved several successes in patent dispute against Hanwha Q-Cells

Retrieved on: 
Wednesday, July 14, 2021

This once again confirmed that LONGi's products did not infringe on Hanwha Q-Cells' US Patent 9,893,215B2, which fully consistent with LONGi's understanding of this patent.

Key Points: 
  • This once again confirmed that LONGi's products did not infringe on Hanwha Q-Cells' US Patent 9,893,215B2, which fully consistent with LONGi's understanding of this patent.
  • It follows LONGi's earlier success in invalidating this patent in another IPR proceeding of Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (USPTO).
  • At the same time, LONGi firmly believes that the relevant products do not infringe the European patent EP2220689B1 within one patent family.
  • The USPTO agreed with LONGi that all of the claims in Hanwha Q-Cells' patent do not fulfill several legal requirements and are unpatentable.

LONGi has achieved several successes in patent dispute against Hanwha Q-Cells

Retrieved on: 
Wednesday, July 14, 2021

This once again confirmed that LONGi's products did not infringe on Hanwha Q-Cells' US Patent 9,893,215B2, which fully consistent with LONGi's understanding of this patent.

Key Points: 
  • This once again confirmed that LONGi's products did not infringe on Hanwha Q-Cells' US Patent 9,893,215B2, which fully consistent with LONGi's understanding of this patent.
  • It follows LONGi's earlier success in invalidating this patent in another IPR proceeding of Patent Trial and Appeal Board of the U.S. Patent and Trademark Office (USPTO).
  • At the same time, LONGi firmly believes that the relevant products do not infringe the European patent EP2220689B1 within one patent family.
  • The USPTO agreed with LONGi that all of the claims in Hanwha Q-Cells' patent do not fulfill several legal requirements and are unpatentable.